ECSP972084A - COMPOSITIONS INCLUDING AN ANTI-FUNGUS AGENT AND AN ACETATE BUFFER - Google Patents
COMPOSITIONS INCLUDING AN ANTI-FUNGUS AGENT AND AN ACETATE BUFFERInfo
- Publication number
- ECSP972084A ECSP972084A ECSP972084A ECSP972084A EC SP972084 A ECSP972084 A EC SP972084A EC SP972084 A ECSP972084 A EC SP972084A EC SP972084 A ECSP972084 A EC SP972084A
- Authority
- EC
- Ecuador
- Prior art keywords
- acetate buffer
- compositions including
- pharmaceutically acceptable
- fungus agent
- effective
- Prior art date
Links
- 239000008351 acetate buffer Substances 0.000 title abstract 2
- 239000003429 antifungal agent Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000004067 bulking agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención es una composición farmacéutica para administración intravenosa a un paciente que comprende: a) una cantidad farmacéuticamente efectiva de un compuesto de fórmula: (gráfico), y las sales farmacéuticamente aceptables del mismo: b) Una cantidad farmacéuticamente aceptable de un excipiente, tal como un agente de volumen, efectivo para formar una torta liofiliazada y: c) una cantidad farmacéuticamente aceptable de tampón acetato, efectivo para proveer un pH alrededor de 4 y 7.The invention is a pharmaceutical composition for intravenous administration to a patient comprising: a) a pharmaceutically effective amount of a compound of the formula: (graph), and the pharmaceutically acceptable salts thereof: b) a pharmaceutically acceptable amount of an excipient, such as a bulking agent, effective in forming a freeze-dried cake and: c) a pharmaceutically acceptable amount of acetate buffer, effective in providing a pH around 4 and 7.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972084 ECSP972084A (en) | 1997-04-16 | 1997-04-16 | COMPOSITIONS INCLUDING AN ANTI-FUNGUS AGENT AND AN ACETATE BUFFER |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972084 ECSP972084A (en) | 1997-04-16 | 1997-04-16 | COMPOSITIONS INCLUDING AN ANTI-FUNGUS AGENT AND AN ACETATE BUFFER |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP972084A true ECSP972084A (en) | 1998-04-24 |
Family
ID=42042916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP972084 ECSP972084A (en) | 1997-04-16 | 1997-04-16 | COMPOSITIONS INCLUDING AN ANTI-FUNGUS AGENT AND AN ACETATE BUFFER |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP972084A (en) |
-
1997
- 1997-04-16 EC ECSP972084 patent/ECSP972084A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4940486A1 (en) | ANTI-FUNGOUS COMPOSITIONS | |
| YU13695A (en) | Application of 2-phenyl-3-aroylbenzothiophene and pharmaceutical formulations thereof | |
| BRPI0011640B8 (en) | oligosaccharide aldonic acids and their topical use | |
| CO4950524A1 (en) | NITRIC ACID SINTASA INHIBITORS | |
| UY26635A1 (en) | SYNERGIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
| NO963053D0 (en) | Cosmetic or pharmaceutical preparations containing mangiferin or derivatives thereof | |
| GEP20002298B (en) | Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment | |
| BR0115109A (en) | Therapeutic agents and methods of their use for angiogenesis modulation | |
| RU94041223A (en) | Agent for motoneuron disease treatment | |
| KR930702022A (en) | Treatment or prevention of type 1 diabetes by oral administration of insulin | |
| ES2178430T3 (en) | USE OF GELIFICABLE PHARMACEUTICAL COMPOSITIONS IN PARODONTOLOGY. | |
| ES2195344T3 (en) | PHARMACEUTICAL COMPOSITION PRESENTING AN IMPROVED ANTITUMORAL ACTIVITY AND / OR REDUCED SIDE EFFECTS, CONTAINING AN ANTITUMORAL AGENT AND A HYDROXYMIC ACID DERIVATIVE. | |
| ES2244625T3 (en) | USE OF BIGUANIDA DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT WITH CICATRIZING EFFECT. | |
| TW427906B (en) | Antifungal compositions | |
| DE69333387D1 (en) | Pharmaceutical compositions containing norastemizole. | |
| WO2002064214A3 (en) | Anti cancer combination of substituted pyrroles and paclitaxel | |
| HUP9802897A2 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
| TR200103144T2 (en) | New compounds | |
| UY26459A1 (en) | 3,4-DIHIDROQUINAZOLINES 5,6-DISSTITUTED | |
| ECSP972084A (en) | COMPOSITIONS INCLUDING AN ANTI-FUNGUS AGENT AND AN ACETATE BUFFER | |
| JPH06211636A (en) | Oral composition | |
| ATE91890T1 (en) | MANUFACTURE OF A DRUG AGAINST ARTHRITIS AND RHEUMATISM. | |
| JPH08245352A (en) | Oral composition | |
| AR005724A1 (en) | BIOLOGICALLY ACTIVE UREID DERIVATIVES USEFUL IN THE TREATMENT OF MULTIPLE SCLEROSIS | |
| ATE223700T1 (en) | NEW INJECTABLE MEDICINAL PREPARATIONS CONTAINING RAMOPLAN |